Profile data is unavailable for this security.
About the company
Jiangsu Kanion Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The Company's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The Company distributes its products mainly within domestic markets.
- Revenue in CNY (TTM)4.87bn
- Net income in CNY543.34m
- Incorporated2000
- Employees5.44k
- LocationJiangsu Kanion Pharmaceutical Co LtdJiangning Industrial ParkEconomic & Technological Development ZneLIANYUNGANG 222047ChinaCHN
- Phone+86 51 885521990
- Fax+86 51 885521990
- Websitehttps://www.kanion.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Runda Medical Technology Co Ltd | 9.75bn | 395.16m | 10.88bn | 3.50k | 27.16 | 2.58 | -- | 1.12 | 0.6687 | 0.6687 | 16.52 | 7.04 | 0.6807 | 4.46 | 1.77 | 2,786,695.00 | 3.92 | 5.45 | 10.28 | 14.05 | 27.46 | 27.35 | 5.76 | 6.85 | 1.09 | 8.56 | 0.5758 | 12.24 | 18.45 | 19.43 | 9.87 | 13.77 | -4.71 | 14.57 |
| Nanjing Vazyme Biotech Co Ltd | 1.29bn | -15.12m | 11.18bn | 2.70k | -- | 2.78 | -- | 8.70 | -0.0368 | -0.0368 | 3.27 | 10.07 | 0.2191 | 0.9761 | 2.85 | 476,061.10 | -0.286 | 13.16 | -0.3724 | 15.92 | 71.31 | 70.50 | -1.31 | 23.92 | 2.97 | -- | 0.2154 | 32.20 | -63.97 | 49.74 | -111.94 | -- | 48.61 | -- |
| Joinn Laboratories China Co Ltd | 2.33bn | -62.99m | 11.33bn | 2.50k | -- | 1.52 | -- | 4.86 | -0.0862 | -0.0862 | 3.12 | 10.75 | 0.23 | 0.6906 | 8.14 | -- | -0.6856 | 8.99 | -0.8219 | 11.07 | 39.46 | 46.76 | -2.98 | 32.01 | 3.51 | 0.9996 | 0.0079 | 23.79 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 2.73bn | 511.96m | 11.41bn | 2.55k | 22.23 | 1.45 | -- | 4.18 | 0.5447 | 0.5447 | 2.90 | 8.35 | 0.2186 | 1.58 | 0.8134 | 1,071,832.00 | 4.06 | 3.48 | 5.61 | 4.78 | 46.09 | 38.93 | 18.56 | 10.08 | 2.35 | -- | 0.2862 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 4.87bn | 543.34m | 11.47bn | 5.44k | 21.00 | 2.13 | -- | 2.35 | 0.9342 | 0.9342 | 8.39 | 9.22 | 0.6915 | 3.50 | 6.92 | 895,523.30 | 7.82 | 6.68 | 10.54 | 9.49 | 72.55 | 74.02 | 11.31 | 10.28 | 2.23 | -- | 0.00 | 25.57 | 11.88 | 4.94 | 23.54 | 5.33 | -1.87 | 35.84 |
| Liaoning Chengda Biotechnology Co Ltd | 1.76bn | 420.34m | 11.78bn | 1.73k | 27.90 | 1.21 | -- | 6.69 | 1.01 | 1.01 | 4.26 | 23.41 | 0.1743 | 0.7061 | 1.61 | 1,016,911.00 | 4.16 | 10.63 | 4.27 | 11.01 | 81.48 | 85.74 | 23.87 | 39.56 | 20.80 | -- | 0.002 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.18bn | 208.25m | 11.94bn | 1.55k | 57.36 | 5.31 | -- | 10.11 | 0.9769 | 0.9769 | 5.54 | 10.55 | 0.3743 | 1.21 | 4.71 | 764,598.40 | 6.69 | 5.86 | 9.15 | 7.59 | 63.15 | 55.41 | 17.87 | 17.20 | 1.08 | 33.77 | 0.3356 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 3.26bn | 453.31m | 12.00bn | 2.88k | 26.47 | 3.07 | -- | 3.68 | 1.05 | 1.05 | 7.56 | 9.08 | 0.6482 | 5.87 | 11.13 | 1,130,851.00 | 9.26 | 10.82 | 11.03 | 13.47 | 42.87 | 41.18 | 14.29 | 14.08 | 5.18 | -- | 0.0729 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 1.80bn | 514.80m | 12.03bn | 2.47k | 23.33 | 2.76 | -- | 6.69 | 1.18 | 1.18 | 4.11 | 9.95 | 0.36 | 2.68 | 6.66 | 727,792.60 | 10.31 | -- | 11.11 | -- | 39.78 | -- | 28.63 | -- | 5.51 | -- | 0.0551 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| Sansure Biotech Inc | 1.20bn | 384.73m | 12.04bn | 2.01k | 31.73 | 1.60 | -- | 10.01 | 0.6448 | 0.6448 | 2.06 | 12.77 | 0.1377 | 0.8274 | 1.41 | 599,646.90 | 4.14 | 26.74 | 4.69 | 30.97 | 74.82 | 67.47 | 30.06 | 42.01 | 7.94 | -- | 0.0589 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
Data as of Apr 18 2024. Currency figures normalised to Jiangsu Kanion Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
17.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Investment Corp. (Investment Management)as of 06 Feb 2024 | 17.89m | 3.10% |
| China Southern Asset Management Co., Ltd.as of 06 Feb 2024 | 11.82m | 2.05% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 10.73m | 1.86% |
| Essence Fund Co., Ltd.as of 30 Jun 2023 | 10.65m | 1.85% |
| Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2023 | 9.51m | 1.65% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 9.16m | 1.59% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 9.06m | 1.57% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 7.75m | 1.35% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2023 | 6.41m | 1.11% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2023 | 6.07m | 1.05% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
